Comparison of two different GnRH analogs  impact on final height in girls with early puberty: Triptorelin acetate vs. leuprolide acetate.

Aka, Sibel; Abali, SAYGIN; Taskin, A; Bengur, F; Semiz, Serap

doi:10.4183/aeb.2020.402

Comparison of two different GnRH analogs impact on final height in girls with early puberty: Triptorelin acetate vs. leuprolide acetate.

Aka S., Abali S., Taskin A., Bengur F. B., Semiz S.

Acta endocrinologica (Bucharest, Romania : 2005), vol.16, no.4, pp.402-408, 2020 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 16 Issue: 4
Publication Date: 2020
Doi Number: 10.4183/aeb.2020.402
Journal Name: Acta endocrinologica (Bucharest, Romania : 2005)
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE
Page Numbers: pp.402-408
Keywords: Early puberty, GnRH analog treatment, Triptorelin acetate, Leuprolide acetate, body mass index, final height, BODY-MASS INDEX, CENTRAL PRECOCIOUS PUBERTY, GONADOTROPIN-SUPPRESSIVE THERAPY, ADULT HEIGHT, HORMONE ANALOGS, GROWTH, REFERENCES, AGONISTS, PATTERN, WEIGHT
Acibadem Mehmet Ali Aydinlar University Affiliated: Yes

Abstract

Context. GnRHa treatment has been a standard of care in progressive early puberty (EP). Choice of the GnRHa formulation is dependent on the preference of the clinician.